[Possibilities of pharmacotherapy in the treatment of abdominal pain syndrom in patients with chronic pancreatitis].
Maev
I V
IV
Kucheriavyĭ
Iu A
IuA
Sviridova
A V
AV
D015746:Abdominal Pain / Q000150:complications / Q000178:diet therapy / Q000188:drug therapy*; D000700:Analgesics / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D015282:Octreotide / Q000008:administration & dosage / Q000627:therapeutic use; D010194:Pancreatin / Q000008:administration & dosage / Q000627:therapeutic use; D050500:Pancreatitis, Chronic / Q000150:complications / Q000178:diet therapy / Q000188:drug therapy* / Q000378:metabolism; D012636:Secretory Rate / Q000187:drug effects; D013004:Somatostatin / Q000008:administration & dosage / Q000627:therapeutic use; D013577:Syndrome; D014357:Trypsin / Q000008:administration & dosage / Q000627:therapeutic use
D000700:Analgesics; D005765:Gastrointestinal Agents; D013004:Somatostatin; D010194:Pancreatin; D014357:Trypsin; D015282:Octreotide